Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GenoLac
Naha, Okinawa, Japan
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
GenoLac BL Corporation is a Japanese biotechnology company specializing in the development of therapeutic vaccines and innovative pharmaceuticals. Founded in 2001 and headquartered in Okinawa, the company leverages a proprietary Lactobacillus display technology to create safe, orally administered vaccines. Its lead candidate, GLBL101c, is a Lactobacillus-based therapeutic vaccine targeting the HPV16 E7 protein for the treatment of high-grade cervical intraepithelial neoplasia (CIN3). GenoLac BL has established strategic partnerships with AnGes and Morishita Jintan to advance its clinical programs and is also exploring treatments for diabetes and fungal infections.
- Therapeutic areas
- OncologyEndocrinologyInfectious Diseases
- Modalities
- Live biotherapeutic product therapyVaccinePeptidesRecombinant protein
- Industry
- Biotech
02
Partnerships
AnGesBioLeadersMorishita Jintan
Beyond the preview
Go deeper on GenoLac.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GenoLac.